NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson’s third-quarter profit jumped 23%, beating Wall Street forecasts, thanks to higher sales of its key medicines for cancer and immune disorders and an acquisition-related charge a year earlier.
Source: World Business